Aggregates in platelet concentrates

Vox Sanguinis

Volumn 108, Issue 1, 2015, Pages 96-100

  van der Meer, Pieter F ^a   Dumont, L J ^b   Lozano, Miguel ^c   Bondar, Noemi ^d   Wong, Janet ^d   Ismay, Sue ^d   Pink, Joanne ^e   Nussbaumer, Walter ^f   Coene, José ^g   Feys, H B ^g   Compernolle, Veerle ^g   Devine, Dana V ^h   Howe, David ⁱ   Lin, Che Kit ^a   Sun, Jenny ^j   Ringwald, Juergen ^k   Strasser, Erwin F ^k   Eckstein, Reinhold ^k   Seltsam, Axel ^l   Perseghin, Paolo ^m   Proserpio, Patrizia ^m   Wakamoto, Shinobu ⁿ   Akino, Mitsuaki ⁿ   Takamoto, Shigeru ⁿ   Tadokoro, Kenji ^o   Teo, Diana ^p   Shu, Pei Huey ^p   Chua, Sze Sze ^p   Jimenez Marco, Teresa ^q   Cid, Joan ^c   Castro, Emma ^r   Muñoz, Irene ^r   Gulliksson, Hans ^s   Sandgren, Per ^s   Thomas, Stephen ^t   Petrik, Juraj ^u   Mccoll, Kevin ^u   Kamel, Hany ^v   Dugger, James ^v   Sweeney, Joseph D ^w   Gorlin, Jed B ^a   Sutor, Laurie J ^x   Heath, Doug ^x   Sayers, Merlyn H ^x   more..

^a Department of Product and Process Development Sanquin Blood Bank ^*  (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c HOSPITAL CLÍNIC   (Spain)

^d Australian Red Cross Blood Service   (Australia)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^g Rode Kruis Vlaanderen   (Belgium)

^h CANADIAN BLOOD SERVICES   (Canada)

ⁱ Supply Chain Process Management   (Canada)

^j Institute of Acupuncture Research   (China)

^k UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^l Institute Springe   (Germany)

^m Servizio di Immunoematologia e Trasfusionale UOS Aferesi e Nuove Tecnologie Trasfusionali A O San Gerardo   (Italy)

ⁿ Japanese Red Cross Hokkaido Blood Center   (Japan)

^o SUWA RED CROSS HOSPITAL   (Japan)

^p HEALTH SCIENCES AUTHORITY   (Singapore)

^q Fundació Banc de Sang i Teixits de les Illes Balears   (Spain)

^r Centro de Transfusion de Cruz Roja Espanola   (Spain)

^s KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^t NHS BLOOD AND TRANSPLANT   (United Kingdom)

^u SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^v Blood Systems Incorporated   (United States)

^w MIRIAM HOSPITAL   (United States)

^x Carter BloodCare   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

APHERESIS; APHERESIS DEVICE; BACTERIUM CONTAMINATION; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CENTRIFUGATION; DISEASE PREDISPOSITION; HUMAN; NOTE; PRIORITY JOURNAL; SEDIMENTATION; SMOKING; SUGGESTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; PROCEDURES;

HUMANS; PLATELET AGGREGATION; PLATELET TRANSFUSION;

EID: 84919469639     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12184     Document Type: Note

References (41)

1. Aster RH Effect of acidification in enhancing viability of platelet concentrates, current status. Vox Sang 1969; 17:23
2. Maurad N: A simple method for obtaining platelet concentrates free of aggregates. Transfusion 1968; 8:48
3. Devine DV, Bradley AJ, Maurer E, et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999; 39:724
4. Valeri CR, McGregor H, Giorgio A, et al. Circulation and distribution of 111 In-oxine-labeled autologous baboon platelet aggregates and buffy coat. Transfus Apher Sci 2005; 32:139
5. Ringwald J, Antoon M, Eckstein R, et al. Residual aggregates in platelet products: what do we know? Vox Sang 2014; 106:209-218
6. Nakajo S, Hirayama F, Niwa K, et al. Clump formation in apheresis platelet concentrates. Transfusion 1999; 39:913-915
7. Skripchenko A, Myrup A, Awatefe H, et al. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage. Transfusion 2012; 52:1433-1438
8. Feys B, Devloo R, De Pourcq K, et al. Apheresis platelet concentrates containing visible particles are not inferior to particle-free concentrates, in vitro. Vox Sang 2013; 105(Suppl. 1):11
9. Sandgren P, Meinke S, Eckert E, et al. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion 2014; 54:602-612
10. Feys B, Devloo R, De Pourcq K, et al. Apheresis platelet concentrates containing visible particles are not inferior to particle-free concentrates, in vitro. Vox Sanguinis 2013; 105(Suppl. 1):11
11. Devine DV, Bradley AJ, Maurer E, et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999; 39:724-734
12. Canadian Blood Services. Visual Assessment Guide 2009. Available from: http://www.transfusionmedicine.ca/sites/trans fusionmedicine/files/PDF/VAG_en.pdf (accessed on June 2013)
13. Ringwald J, Eckstein R, Antoon M, et al. Occurrence of residual aggregates in single donor platelet concentrates in routine blood banking. Vox Sang 2013; 105(Suppl. 1):142-143
14. Ringwald J, Tully S, Geier C, et al. Effects of immediate or delayed hold time prior to platelet additive solution addition on the in-vitro quality of apheresis platelets. Transfusion 2012; 52:1237-1244
15. Jimenez TM, Patel SB, Pineda AA, et al. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003; 43:328-334
16. Macher S, Sipurzynski-Budrass S, Rosskopf K, et al. Function and activation state of platelets in vitro depend on apheresis modality. Vox Sang 2010; 99:332-340
17. Skripchenko A, Kurtz J, Moroff G, et al. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008; 48:1469-1477
18. Sweeney JD, Dupuis M, Testa G Lack of macroscopic aggregates in pools of pre-storage WBC-reduced random-donor platelet concentrates prepared from whole blood. Transfusion 2000; 40:615-616
19. Stohlawetz P, Kapiotis S, Seidl D, et al. Safety issue of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophil and the formation of neutrophil-platelet aggregates. Transfusion 1999; 39:420-427
20. Pretorius E, Crockers R, Oberholzer HM, et al. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure. Transfus Apher Sci 2010; 43:347-351
21. Ringwald J, Walz S, Zimmermann R, et al. Hyperconcentrated platelets stored in additive solution: aspect on productivity and in vitro quality. Vox Sang 2005; 89:11-18
22. Flesch BK, Adamzik I, Steppat D, et al. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort. Transfusion 2010; 50:894-901
23. Perseghin P, Mascaretti L, Belotti D, et al. Platelet activation during multi-component (MC) collection: a comparison between Cobe Trima and Spectra LRS Turbo cell separators. Transfusion 2004; 44:125-130
24. Nakajo S, Hirayama F, Niwa K, et al. Clump formation in apheresis platelet concentrates. Vox Sang 1999; 39:913-914
25. Ringwald J, Zimmermann R, Eckstein R The new generation of platelet additive solution for storage at 22 degrees C: development and current experience. Transfus Med Rev 2006; 20:158-164
26. Jiménez TM, Patel SB, Pineda AA, et al. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003; 43:328-334
27. Van der Planken MG, Vertessen F, Mortelmans E, et al. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method. Ann Hematol 1999; 78:1-7
28. Kattlove HE, Alexander B The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood 1971; 38:39-48
29. Holme S, Sweeney JD, Sawyer S, et al. The expression of p-selectin during collection, processing and storage of platelet concentrates: relationship to loss in vivo viability. Transfusion 1997; 37:12-17
30. Berger G, Hartwell DW, Wagner DD P-selectin and platelet clearance. Blood 1998; 92:4446-4452
31. Lozano M, Cid J, Areal C, et al. Apheresis activity in Spain: a survey of the Spanish Apheresis Group. Transfus Apher Sci 2013; 49:560-564
32. Lozano M, Narvaez J, Faundez A, et al. Recuento de plaquetas y volumen plaquetario medio en la poblaciön española. Med Clin (Barc) 1998; 110:774-777
33. van der Meer PF, de Korte D Platelet additive solutions; in Sweeney J, Lozano M (eds): Platelet Transfusion Therapy. Bethesda, MD, AABB Press, 2013:75-118
34. Massini P, Lüscher EF The induction of the release reaction in human blood platelets by close cell contact. Thromb Diath Haemorrh 1971; 25:13-20
35. Holmsen H, Setkowsky-Dangelmaier CA Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ATP. Biochim Biophys Acta 1977; 497:46-61
36. Sandgren P, Meinke S, Eckert E, et al. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immodulatory factors sCD40L and RANTES. Transfusion 2014; 54:602-612
37. Sweeney JD, Holme S, Heaton WAL, et al. White cell reduced platelet concentrates prepared by in-line filtration of platelet rich plasma. Transfusion 1995; 35: 131-136
38. Sweeney JD, Kouttab NM, Holme SH, et al. Prestorage pooled whole blood derived leukoreduced platelets stored for seven days preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 2004; 44:1212- 1219
39. Sweeney JD, Dupuis MP, Testa G Lack of macroscopic aggregates in pools of prestorage leukoreduced whole blood derived platelets. Transfusion 2000; 40:615-616
40. Sweeney JD, Kouttab NM, Holme SH, et al. In vitro evaluation of prestorage pools consisting of mixed A and O platelets. Transfusion 2007; 47:1154-1161
41. Rentas FJ, Macdonald VW, Rothwell SW, et al. White particulate matter found in blood collection bags consist of platelets and leukocytes. Transfusion 2004; 44:959-966